KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Current Assets: 2010-2025

Historic Current Assets for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to $786.9 million.

  • Emergent BioSolutions' Current Assets rose 18.97% to $786.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $786.9 million, marking a year-over-year increase of 18.97%. This contributed to the annual value of $598.7 million for FY2024, which is 11.89% down from last year.
  • Per Emergent BioSolutions' latest filing, its Current Assets stood at $786.9 million for Q3 2025, which was up 9.37% from $719.5 million recorded in Q2 2025.
  • Over the past 5 years, Emergent BioSolutions' Current Assets peaked at $1.3 billion during Q4 2021, and registered a low of $598.7 million during Q4 2024.
  • For the 3-year period, Emergent BioSolutions' Current Assets averaged around $746.3 million, with its median value being $706.8 million (2025).
  • Per our database at Business Quant, Emergent BioSolutions' Current Assets surged by 88.49% in 2021 and then crashed by 44.13% in 2024.
  • Quarterly analysis of 5 years shows Emergent BioSolutions' Current Assets stood at $1.3 billion in 2021, then decreased by 4.69% to $1.2 billion in 2022, then plummeted by 43.86% to $679.5 million in 2023, then declined by 11.89% to $598.7 million in 2024, then grew by 18.97% to $786.9 million in 2025.
  • Its Current Assets was $786.9 million in Q3 2025, compared to $719.5 million in Q2 2025 and $706.8 million in Q1 2025.